Exodus Point Capital Management, LP Heron Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$2.25 - $4.67 $23,143 - $48,035	10,286 Added 2.49%	423,898 $1.06 Million
Q3 2022 Nov 10, 2022	BUY	$2.66 - $5.37 $748,414 - $1.51 Million	281,359 Added 212.74%	413,612 $1.75 Million
Q2 2022 Aug 19, 2022	SELL	$2.3 - $6.29 $81,072 - $221,716	-35,249 Reduced 21.04%	132,253 $369,000
Q1 2022 May 13, 2022	BUY	$4.63 - $9.94 $463,180 - $994,387	100,039 Added 148.29%	167,502 $958,000
Q4 2021 Feb 11, 2022	BUY	$8.35 - $12.6 $563,316 - $850,033	67,463 New	67,463 $616,000
Q2 2021 Aug 16, 2021	SELL	$13.27 - $18.48 $353,340 - $492,066	-26,627 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$14.49 - $20.72 $385,825 - $551,711	26,627 New	26,627 $432,000
Q4 2020 Feb 16, 2021	SELL	$14.61 - $22.14 $908,888 - $1.38 Million	-62,210 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$13.67 - $17.77 $105,204 - $136,757	-7,696 Reduced 11.01%	62,210 $922,000
Q2 2020 Aug 14, 2020	BUY	$10.89 - $21.47 $761,276 - $1.5 Million	69,906 New	69,906 $1.03 Million

179

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $184M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.